Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17312332 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Epoetin Alfa in Advanced Non-Small Cell Lung Cancer (EPO-CAN-20)
Conditions: Non-Small-Cell Lung Carcinoma;   Lung Cancer;   Anemia
Intervention: Drug: Epoetin Alfa

Indicates status has not been verified in more than two years